[Patient with HCV chronic hepatitis who has subcutaneous nodules after finishing treatment with pegylated interferon]

Rev Clin Esp. 2005 Dec;205(12):621-2. doi: 10.1016/s0014-2565(05)72656-4.

[Article in Spanish]

Authors

F Salgado Ordóñez¹, R Manteca González, S Palacios Rodríguez, M Godoy Guerrero

Affiliation

¹ Servicio de Medicina, Hospital de la Serranía, Ronda.

PMID: 16527184
DOI: 10.1016/s0014-2565(05)72656-4

No abstract available

Publication types

Case Reports

MeSH terms

Antiviral Agents / adverse effects*
Antiviral Agents / therapeutic use
Diabetes Mellitus, Type 2 / complications
Drug Therapy, Combination
Hepatitis C, Chronic / complications
Hepatitis C, Chronic / drug therapy*
Humans
Hypertension / complications
Interferon alpha-2
Interferon-alpha / adverse effects*
Interferon-alpha / therapeutic use
Middle Aged
Polyethylene Glycols
Recombinant Proteins
Ribavirin / therapeutic use
Sarcoidosis / chemically induced*
Sarcoidosis / diagnosis

Substances

Antiviral Agents
Interferon alpha-2
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols
Ribavirin
peginterferon alfa-2b